The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, C.-H.
Right arrow Articles by Levitsky, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, C.-H.
Right arrow Articles by Levitsky, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A
The Journal of Immunology, 2001, 166: 989-995.
Copyright © 2001 by The American Association of Immunologists

Different Programs of Activation-Induced Cell Death Are Triggered in Mature Activated CTL by Immunogenic and Partially Agonistic Peptide Ligands1

Cheng-Hong Wei*, Hideo Yagita{dagger}, Maria G. Masucci* and Victor Levitsky2,*

* Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden; and {dagger} Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan

Activation-induced cell death (AICD) of mature T cells plays an important role in the control of immune homeostasis and peripheral tolerance. TNFRs and Fas have been implicated in the induction of AICD. However, these molecules were shown to be dispensable, at least in some experimental systems, for downsizing of Ag-induced T cell expansions and development of tolerance in vivo. The conditions of T cell activation leading to T cell deletion in a death receptor-independent manner are not well characterized. Here we show that human CTLs die through a death receptor-independent apoptotic program upon triggering with a partially agonistic peptide ligand. This apoptotic process exhibits some features of T cell death due to lymphokine deprivation and is blocked by exogenous IL-2. Our data demonstrate that engagement of TCR by MHC-peptide complexes can trigger diverse apoptotic programs of AICD and that the choice between these programs is determined by the agonistic potency of MHC-peptide ligand.




This article has been cited by other articles:


Home page
J. Virol.Home page
P. Sen, W. A. Charini, R. A. Subbramanian, E. R. Manuel, M. J. Kuroda, P. A. Autissier, and N. L. Letvin
Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge
J. Virol., January 15, 2008; 82(2): 805 - 816.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Fischer, S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mackensen
Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells
Blood, December 15, 2006; 108(13): 4094 - 4101.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kennedy and E. Celis
T Helper Lymphocytes Rescue CTL from Activation-Induced Cell Death.
J. Immunol., September 1, 2006; 177(5): 2862 - 2872.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Uhlin, M. G. Masucci, and V. Levitsky
Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes
PNAS, June 28, 2005; 102(26): 9264 - 9269.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kan-Mitchell, B. Bisikirska, F. Wong-Staal, K. L. Schaubert, M. Bajcz, and M. Bereta
The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope
J. Immunol., May 1, 2004; 172(9): 5249 - 5261.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Sandalova, C.-H. Wei, M. G. Masucci, and V. Levitsky
Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering
PNAS, March 2, 2004; 101(9): 3011 - 3016.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Nilges, H. Hohn, H. Pilch, C. Neukirch, K. Freitag, P. J. Talbot, and M. J. Maeurer
Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein
J. Virol., May 1, 2003; 77(9): 5464 - 5474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Li, D. Liu, L. Hutt-Fletcher, A. Morgan, M. G. Masucci, and V. Levitsky
Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4
Blood, May 15, 2002; 99(10): 3725 - 3734.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-i. Fujii, K. Shimizu, T. Shimizu, and M. T. Lotze
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
Blood, October 1, 2001; 98(7): 2143 - 2151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.